JP2007502861A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007502861A5 JP2007502861A5 JP2006532538A JP2006532538A JP2007502861A5 JP 2007502861 A5 JP2007502861 A5 JP 2007502861A5 JP 2006532538 A JP2006532538 A JP 2006532538A JP 2006532538 A JP2006532538 A JP 2006532538A JP 2007502861 A5 JP2007502861 A5 JP 2007502861A5
- Authority
- JP
- Japan
- Prior art keywords
- trna synthetase
- composition
- pharmaceutically acceptable
- synthetase inhibitor
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46737703P | 2003-05-01 | 2003-05-01 | |
| US48648203P | 2003-07-10 | 2003-07-10 | |
| PCT/US2004/013614 WO2005009336A2 (en) | 2003-05-01 | 2004-05-03 | Antibacterial methods and compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007502861A JP2007502861A (ja) | 2007-02-15 |
| JP2007502861A5 true JP2007502861A5 (enExample) | 2007-06-21 |
Family
ID=34107519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006532538A Pending JP2007502861A (ja) | 2003-05-01 | 2004-05-03 | 抗菌方法及び組成物 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20040224981A1 (enExample) |
| EP (1) | EP1619947A4 (enExample) |
| JP (1) | JP2007502861A (enExample) |
| AU (1) | AU2004258821A1 (enExample) |
| CA (1) | CA2523651A1 (enExample) |
| WO (1) | WO2005009336A2 (enExample) |
Families Citing this family (44)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004218481A1 (en) * | 2003-03-03 | 2004-09-16 | Replidyne Inc | Substituted thiophenes with antibacterial activity |
| AU2006226750B2 (en) | 2005-03-23 | 2012-07-19 | Oculus Innovative Sciences, Inc. | Method of treating skin ulcers using oxidative reductive potential water solution |
| CA2606804A1 (en) * | 2005-05-03 | 2006-11-09 | Ranbaxy Laboratories Limited | Antimicrobial agents |
| WO2007085018A2 (en) | 2006-01-20 | 2007-07-26 | Oculus Innovative Sciences, Inc. | Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution |
| AU2007300290B2 (en) * | 2006-09-26 | 2012-11-15 | Crestone, Inc. | Enantiomeric compounds with antibacterial activity |
| ES2392897T3 (es) * | 2006-09-26 | 2012-12-14 | Crestone, Inc. | Compuestos tienopiridona sustituidos con actividad antibacteriana |
| WO2010099477A2 (en) | 2009-02-27 | 2010-09-02 | Atyr Pharma, Inc. | Polypeptide structural motifs associated with cell signaling activity |
| CN102480972B (zh) | 2009-06-15 | 2014-12-10 | 奥古露丝创新科学公司 | 含有次氯酸的溶液及其使用方法 |
| JP6066900B2 (ja) | 2010-04-26 | 2017-01-25 | エータイアー ファーマ， インコーポレイテッド | システイニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| US8961960B2 (en) | 2010-04-27 | 2015-02-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
| ES2638311T3 (es) | 2010-04-27 | 2017-10-19 | Atyr Pharma, Inc. | Descubrimiento innovador de composiciones terapéuticas, diagnósticas y de anticuerpos relacionadas con fragmentos de proteína de treonil ARNt sintetasas |
| JP6008837B2 (ja) | 2010-04-28 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | アラニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| US8986680B2 (en) | 2010-04-29 | 2015-03-24 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases |
| WO2011139907A2 (en) | 2010-04-29 | 2011-11-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
| CA2797799C (en) | 2010-05-03 | 2020-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of seryl-trna synthetases |
| JP6008841B2 (ja) | 2010-05-03 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | メチオニルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| AU2011248227B2 (en) | 2010-05-03 | 2016-12-01 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
| US8961961B2 (en) | 2010-05-03 | 2015-02-24 | a Tyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related protein fragments of arginyl-tRNA synthetases |
| EP2566499B1 (en) | 2010-05-04 | 2017-01-25 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex |
| JP6008843B2 (ja) | 2010-05-04 | 2016-10-19 | エータイアー ファーマ， インコーポレイテッド | グルタミル−プロリルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| EP2568996B1 (en) | 2010-05-14 | 2017-10-04 | aTyr Pharma, Inc. | Therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
| AU2011256366C1 (en) | 2010-05-17 | 2017-06-15 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
| CN103096913B (zh) | 2010-05-27 | 2017-07-18 | Atyr 医药公司 | 与谷氨酰胺酰‑tRNA合成酶的蛋白片段相关的治疗、诊断和抗体组合物的创新发现 |
| CA2800281C (en) | 2010-06-01 | 2021-01-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
| CA2804416C (en) | 2010-07-12 | 2020-04-28 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
| US8999321B2 (en) | 2010-07-12 | 2015-04-07 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-tRNA synthetases |
| CA2804278C (en) | 2010-07-12 | 2021-07-13 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases |
| KR20130102534A (ko) | 2010-07-12 | 2013-09-17 | 에이티와이알 파마, 인코포레이티드 | 히스티딜trna 합성효소의 단백질 단편에 관련된 치료적, 진단적, 및 항체 조성물의 혁신적 발견 |
| WO2012014109A1 (en) | 2010-07-30 | 2012-02-02 | Ranbaxy Laboratories Limited | Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents |
| JP5964304B2 (ja) | 2010-08-25 | 2016-08-03 | エータイアー ファーマ， インコーポレイテッド | チロシルｔＲＮＡ合成酵素のタンパク質フラグメントに関連した治療用、診断用および抗体組成物の革新的発見 |
| EP2624857B1 (en) | 2010-10-06 | 2017-08-02 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tryptophanyl trna synthetases |
| JP2013538868A (ja) * | 2010-10-08 | 2013-10-17 | ヘルパービー セラピューティクス リミテッド | 新規な組成物 |
| WO2012054738A1 (en) * | 2010-10-22 | 2012-04-26 | Brown University | Combination of an aminoacyl - trna synthetase inhibitor with a further antibacterial agent for attenuating multiple drug resistance |
| US9714419B2 (en) | 2011-08-09 | 2017-07-25 | Atyr Pharma, Inc. | PEGylated tyrosyl-tRNA synthetase polypeptides |
| US9816084B2 (en) | 2011-12-06 | 2017-11-14 | Atyr Pharma, Inc. | Aspartyl-tRNA synthetases |
| WO2013086228A1 (en) | 2011-12-06 | 2013-06-13 | Atyr Pharma, Inc. | Pegylated aspartyl-trna synthetase polypeptides |
| CA2858613A1 (en) | 2011-12-29 | 2013-08-08 | Atyr Pharma, Inc. | Aspartyl-trna synthetase-fc conjugates |
| CA2869717C (en) | 2012-04-13 | 2022-09-06 | Becton, Dickinson And Company | Reflex testing of samples using residual materials from a prior test |
| ES2708565T3 (es) | 2013-03-15 | 2019-04-10 | Atyr Pharma Inc | Conjugados de Fc-histidil-ARNt sintetasa |
| US10913736B2 (en) | 2014-08-22 | 2021-02-09 | University Of Washington | Specific inhibitors of methionyl-tRNA synthetase |
| JP2019196307A (ja) | 2016-09-15 | 2019-11-14 | 武田薬品工業株式会社 | 複素環アミド化合物 |
| EP3612215B1 (en) | 2017-04-20 | 2024-08-28 | aTyr Pharma, Inc. | Compositions for treating lung inflammation |
| US11261201B2 (en) | 2018-01-12 | 2022-03-01 | President And Fellows Of Harvard College | TRNA synthetase inhibitors |
| TW202214611A (zh) * | 2020-08-25 | 2022-04-16 | 大陸商杭州中美華東製藥有限公司 | 莫匹羅星的提取方法 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1196284A (en) * | 1982-05-28 | 1985-11-05 | Joshua Oduro-Yeboah | Pharmaceutical formulations |
| GB8415579D0 (en) * | 1984-06-19 | 1984-07-25 | Beecham Group Plc | Compounds |
| IE59628B1 (en) * | 1986-06-26 | 1994-03-09 | Beecham Group Plc | Treatment of fungal infections |
| AU692486B2 (en) * | 1993-10-22 | 1998-06-11 | Smithkline Beecham Corporation | Pharmaceutical or veterinary composition comprising mupirocin or a salt thereof in a cream base |
| GB9424562D0 (en) * | 1994-12-06 | 1995-01-25 | Giltech Ltd | Product |
| GB9507825D0 (en) * | 1995-04-18 | 1995-05-31 | Wet Pieter M De | Method of treatment |
| US5726195A (en) * | 1995-07-28 | 1998-03-10 | Cubist Pharmaceuticals, Inc. | Aminoacyl adenylate mimics as novel antimicrobial and antiparasitic agents |
| US6169102B1 (en) * | 1996-06-25 | 2001-01-02 | Takeda Chemical Industries, Ltd. | Oxazolone derivatives and their use as anti-Helicobacter pylori agent |
| US6448059B1 (en) * | 1996-09-13 | 2002-09-10 | Thomas Jefferson University | Methods and composition for inhibition of tRNA activities |
| US5824657A (en) * | 1997-03-18 | 1998-10-20 | Cubist Pharmaceuticals, Inc. | Aminoacyl sulfamides for the treatment of hyperproliferative disorders |
| US5939458A (en) * | 1997-09-22 | 1999-08-17 | Henry; James P. | Reduction of hair growth |
| JP2002513005A (ja) * | 1998-04-29 | 2002-05-08 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | Ｍｒｓ阻害剤および殺菌剤用のキノロン類 |
| AU5822099A (en) * | 1998-09-18 | 2000-04-10 | Cubist Pharmaceuticals, Inc. | Tetracyclic heterocycles as antimicrobial agents |
| GB9822241D0 (en) * | 1998-10-12 | 1998-12-09 | Smithkline Beecham Plc | Novel compounds |
| AU769652B2 (en) * | 1999-05-05 | 2004-01-29 | Cubist Pharmaceuticals, Inc. | Novel prolines as antimicrobial agents |
| AU776773B2 (en) * | 1999-05-05 | 2004-09-23 | Cubist Pharmaceuticals, Inc. | Novel catechols as antimicrobial agents |
| JP2003500397A (ja) * | 1999-05-19 | 2003-01-07 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Ｍｒｓ阻害剤としての２−ｎｈ−ピリドンおよびピリミドン |
| GB9911594D0 (en) * | 1999-05-19 | 1999-07-21 | Smithkline Beecham Plc | Novel compounds |
| IL137363A (en) * | 2000-07-18 | 2005-12-18 | Agis Ind 1983 Ltd | Pharmaceutical compositions containing mupirocin |
| GB0228545D0 (en) * | 2002-12-06 | 2003-01-15 | Glaxo Group Ltd | Novel compounds |
| GB0302546D0 (en) * | 2003-02-04 | 2003-03-12 | Glaxo Group Ltd | Novel compounds |
| AU2004218481A1 (en) * | 2003-03-03 | 2004-09-16 | Replidyne Inc | Substituted thiophenes with antibacterial activity |
| DE10318991A1 (de) * | 2003-04-25 | 2004-11-18 | Heraeus Kulzer Gmbh & Co. Kg | Poröser Körper mit antibiotischer Beschichtung, Verfahren zur Herstellung sowie Verwendung |
-
2004
- 2004-05-03 US US10/837,881 patent/US20040224981A1/en not_active Abandoned
- 2004-05-03 CA CA002523651A patent/CA2523651A1/en not_active Abandoned
- 2004-05-03 JP JP2006532538A patent/JP2007502861A/ja active Pending
- 2004-05-03 AU AU2004258821A patent/AU2004258821A1/en not_active Abandoned
- 2004-05-03 EP EP04775930A patent/EP1619947A4/en not_active Withdrawn
- 2004-05-03 WO PCT/US2004/013614 patent/WO2005009336A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007502861A5 (enExample) | ||
| JP2021063088A5 (enExample) | ||
| CN1878757A (zh) | 吡啶酮衍生物及其应用 | |
| AR055363A1 (es) | Formulaciones farmaceuticas que comprenden un beta 2- agonista de accion prolongada para administracion por nebulizacion | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| HRP20120494T1 (hr) | Derivati purina za uporabu kao agonista adenozin a2a receptora | |
| JP2009545603A5 (enExample) | ||
| RU2009126767A (ru) | Производное 1-фенил-1-тио-d-глюцитола | |
| HRP20211762T1 (hr) | Derivati benzoksaborola za liječenje bakterijskih infekcija | |
| AR050838A1 (es) | Formulacion farmaceutica. para el tratamiento de una infeccion optica | |
| JP2009544665A5 (enExample) | ||
| RU2011138962A (ru) | Производные 4-изопропилфенилглюцита в качестве ингибиторов sglt1 | |
| EP1816122A3 (en) | 3,4,5-substituted piperidines as therapeutic compounds | |
| JP2005508368A5 (enExample) | ||
| RU2002100058A (ru) | Кристаллические производные 1-метилкарбапенема | |
| DE502004006500D1 (de) | Pharmazeutische formulierung des telmisartan natriumsalzes | |
| AR038618A1 (es) | Forma poliformica cristalina de clorhidratos de irinotecan | |
| JP2004532828A5 (enExample) | ||
| EP1885380A4 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING ARSENE (III ACID), SODIUM SALT AND THEIR DERIVATIVES FOR THE TREATMENT OF UROGENITAL CANCER AND METASTASES THEREOF | |
| FR2906140B1 (fr) | Forme galenique pour l'administration par voie trans-muqueuse de principes actifs | |
| RU2005128132A (ru) | Лечение бактериальных заболеваний органов дыхания путем местного применения фторхинолонов | |
| BR9807330A (pt) | Agentes inibidores do progresso de pterìgio e recorrência pós-operatória do mesmo | |
| JP2005511708A5 (enExample) | ||
| EP1867329A3 (en) | 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamides as therapeutic compounds | |
| JP2007153892A5 (enExample) |